Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,818 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05182112 | Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer with Homologous Recombination Deficiency That Has Spread to the Liver | completed | Phase 1 | 1 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT01755975 | Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma | completed | Phase 1 / Phase 2 | 49 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 7, 2024 |
| clinicaltrials |
| NCT02199236 | Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Nov 1, 2024 | clinicaltrials |
| NCT06218667 | A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 0 | Oct 31, 2024 | clinicaltrials |
| NCT01393483 | Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC) | completed | — | 371 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 28, 2024 | clinicaltrials |
| NCT01766739 | Intra-pleural Administration of GL-ONC1, a Genetically Modified Vaccinia Virus, in Patients With Malignant Pleural Effusion: Primary, Metastases and Mesothelioma | completed | Phase 1 | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 26, 2024 | clinicaltrials |
| NCT02833233 | A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer | completed | N/A | 5 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 23, 2024 | clinicaltrials |
| NCT02902107 | Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet | completed | Phase 1 | 14 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 21, 2024 | clinicaltrials |
| NCT03843775 | A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers | completed | Phase 1 / Phase 2 | 17 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 21, 2024 | clinicaltrials |
| NCT03507725 | Early Staged Consent Before Prostate Biopsy | completed | N/A | 390 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT03070301 | A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors | completed | Phase 2 | 21 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 10, 2024 | clinicaltrials |
| NCT03879798 | DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 22 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 10, 2024 | clinicaltrials |
| NCT01899989 | Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer | completed | Phase 1 | 39 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 4, 2024 | clinicaltrials |
| NCT00582257 | Early Onset and Familial Gastric Cancer Registry | completed | — | 971 | Memorial Sloan Kettering Cancer CenterOTHER | 2 | Oct 3, 2024 | clinicaltrials |
| NCT01774071 | Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer | completed | Phase 1 / Phase 2 | 19 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 2, 2024 | clinicaltrials |
| NCT00580476 | Assessing Depression in a Geriatric Cancer Population | completed | — | 201 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT00773773 | Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer | terminated | N/A | 58 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 4, 2024 | clinicaltrials |
| NCT02633137 | Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma | completed | Phase 2 | 49 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 30, 2024 | clinicaltrials |
| NCT05966584 | A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer | terminated | Phase 2 | 1 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT03056638 | Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer | terminated | Phase 3 | 56 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT04171895 | Communication Training for Caregivers In Advanced Care Planning | completed | — | 49 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 26, 2024 | clinicaltrials |
| NCT03667482 | Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer | completed | Phase 1 | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 23, 2024 | clinicaltrials |
| NCT01894672 | BRAF Inhibitor, LGX818, Utilizing a Pulsatile Schedule in Patients With Stage IV or Unresectable Stage III Melanoma Characterized by a BRAFV600 Mutation | completed | Phase 2 | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT03681483 | RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer | completed | Phase 1 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT01323309 | Trial of Individual Psychosocial Interventions for Cancer Patients | completed | — | 346 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT00002981 | PET Scan in Treating Patients With Metastatic Prostate Cancer | completed | N/A | 173 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 3, 2024 | clinicaltrials |
| NCT02350764 | Evaluate the Mediators of Sensitivity and Resistance to Nivolumab Plus Ipilimumab in Patients With Advanced NSCLCs | completed | Phase 2 | 29 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 29, 2024 | clinicaltrials |
| NCT03319537 | Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma | terminated | Phase 1 / Phase 2 | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT01995578 | Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse | completed | Phase 2 | 32 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT01345175 | Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer | completed | Phase 3 | 69 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT02697383 | Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study | completed | Phase 1 | 14 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT03183037 | Acupuncture for Symptoms of Nerve Damage | completed | N/A | 75 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT02571673 | Feasibility Study of the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR) | completed | — | 65 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT00494910 | Randomized Controlled Trial of Group Psychotherapy Interventions for Cancer Patients | completed | Phase 3 | 253 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT02615054 | Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer Survivors | completed | — | 58 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT03810105 | A Study of Olaparib and Durvalumab in Prostate Cancer | terminated | Phase 2 | 5 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT01916122 | Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status | completed | Early Phase 1 | 54 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT00445965 | Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer | completed | Phase 2 | 78 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT02341014 | Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas | completed | Phase 1 / Phase 2 | 27 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT03076164 | A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib | completed | Phase 1 / Phase 2 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT00596154 | Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma(PCNSL) | completed | Phase 2 | 33 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 1, 2024 | clinicaltrials |
| NCT03454295 | Easing Psychosocial Burden for Informal Caregivers | completed | Early Phase 1 | 64 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 1, 2024 | clinicaltrials |
| NCT03885908 | Automated Geriatric Co-Management Program in Older Patients With Solid Mass or Nodule Suspicious for Cancer | terminated | N/A | 20 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT02145871 | A Prospective Randomized Controlled Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Radical Cystectomy | completed | Phase 3 | 282 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT02282358 | Study of Mocetinostat in Selected Patients With Mutations of Acetyltransferase Genes in Relapsed and Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma | terminated | Phase 1 / Phase 2 | 7 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT03508765 | Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation | completed | N/A | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT02280356 | Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer | completed | Phase 2 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT03530969 | Geriatric Communication Skills Training Program for Oncology Clinicians | completed | N/A | 88 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT04478123 | Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer | completed | Phase 2 | 62 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 14, 2024 | clinicaltrials |
| NCT01995708 | CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation | completed | Phase 1 | 28 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 9, 2024 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials